Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab
Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.
Authors
- Samuel T. Luebbe
- Mohamed Al‐Kazaz (ORCID: https://orcid.org/0009-0003-9357-0175)
- Toluwalase Awoyemi (ORCID: https://orcid.org/0000-0003-1542-9435)
- Adam Yuh Lin (ORCID: https://orcid.org/0000-0001-9359-882X)
- Emma G. Kilbane
- Jayesh Mehta
- Alexander Hurtado
- Taylor Bronson
Institutions
- Northwestern University (US)
- Northwestern Medicine (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.jaccas.2024.102763
- Citations
- 2
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.91